Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods
出版年份 2016 全文链接
标题
Screening for major driver oncogene alterations in adenosquamous lung carcinoma using PCR coupled with next-generation and Sanger sequencing methods
作者
关键词
-
出版物
Scientific Reports
Volume 6, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-29
DOI
10.1038/srep22297
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidermal growth factor receptor gene mutation status in pure squamous-cell lung cancer in Chinese patients
- (2015) Qing Zhang et al. BMC CANCER
- The Long-term Survival of a Patient with Adenosquamous Lung Carcinoma Harboring EGFR-activating Mutations Who was Treated with Gefitinib
- (2014) Kentaro Iwanaga et al. INTERNAL MEDICINE
- Epidermal growth factor receptor (EGFR) exon 20 mutations in non-small-cell lung cancer and resistance to EGFR-tyrosine kinase inhibitors
- (2014) Hyun Sun Woo et al. INVESTIGATIONAL NEW DRUGS
- Analysis of Major Known Driver Mutations and Prognosis in Resected Adenosquamous Lung Carcinomas
- (2014) Rui Wang et al. Journal of Thoracic Oncology
- Dramatic Response Induced by Vemurafenib in aBRAFV600E-Mutated Lung Adenocarcinoma
- (2013) Solange Peters et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapeutic efficacy of gefitinib and erlotinib in patients with advanced lung adenosquamous carcinoma
- (2013) Zhengbo Song et al. Journal of the Chinese Medical Association
- Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysis
- (2013) Daquan Meng et al. LUNG CANCER
- Prognostic value of epidermal growth factor receptor mutations in resected lung adenocarcinomas
- (2013) Wei-shuai Liu et al. MEDICAL ONCOLOGY
- Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy
- (2013) Fumie Yamashita et al. PLoS One
- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
- (2012) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib
- (2012) Oliver Gautschi et al. Journal of Thoracic Oncology
- Thymidylate synthase expression and molecular alterations in adenosquamous carcinoma of the lung
- (2012) Catherine Shu et al. MODERN PATHOLOGY
- Adenosquamous Carcinoma of the Lung
- (2011) Naobumi Tochigi et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung
- (2011) Xiao-Li Jia et al. LUNG CANCER
- Coexistence of PIK3CA and Other Oncogene Mutations in Lung Adenocarcinoma-Rationale for Comprehensive Mutation Profiling
- (2011) J. E. Chaft et al. MOLECULAR CANCER THERAPEUTICS
- Relationship between EGFR expression, copy number and mutation in lung adenocarcinomas
- (2010) Zhiyong Liang et al. BMC CANCER
- Clinicopathological characteristics of resected adenosquamous cell carcinoma of the lung: Risk of coexistent double cancer
- (2010) Hidetaka Uramoto et al. Journal of Cardiothoracic Surgery
- Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer
- (2010) Mark Nuijten et al. LUNG CANCER
- The different clinical significance of EGFR mutations in exon 19 and 21 in non-small cell lung cancer patients of China
- (2010) M. LI et al. NEOPLASMA
- Activating mutations within the EGFR kinase domain: a molecular predictor of disease-free survival in resected pulmonary adenocarcinoma
- (2009) Young Joo Lee et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer
- (2009) Meina Wu et al. LUNG CANCER
- PIK3CA Mutations and Copy Number Gains in Human Lung Cancers
- (2008) H. Yamamoto et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started